DiviDrip · IPSC

IPSC — Century Therapeutics, Inc.

IPSC is Century Therapeutics, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $2.11. Market cap: $382M. Capital Quality Rank: 62/100 — Above average.

Stock snapshot

Price$2.11
Market cap$382M
SectorHealthcare
ExchangeNCM
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)62 / 100 · Above average
ROIC (TTM)-14.1%
Revenue CAGR (3y)175.9%
Shareholder buyback yield-9.14%
Altman Z-score zoneDistress

About IPSC

Century Therapeutics Inc is a biotechnology company harnessing the power of allogeneic pluripotent stem cell therapies to develop potentially curative cell therapy products for autoimmune diseases, including type 1 diabetes, or T1D, and cancer. Its beta islet, T cell and NK cell programs are allogeneic, meaning it is derived from healthy donors for use in any patient, rather than being sourced from an individual for their own specific use, as is the case with autologous T cells. The cell types it can generate from iPSCs, including iPSC-derived beta islet cells, iPSC-derived CD4+ and CD8+ alphabeta T cells, or alphabeta iT cells, and iPSC- natural killer cells, or iNK cells.

Listed2021Employees78HQPhiladelphia, PASectorHealthcareWebsitecenturytx.com

Related non-dividend companies

Other non-dividend stocks investors research alongside IPSC. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is IPSC's current stock price?

IPSC (Century Therapeutics, Inc.) is currently trading at $2.11.

Does IPSC pay a dividend?

IPSC (Century Therapeutics, Inc.) does not currently pay a regular dividend.

What is IPSC's Capital Quality Rank?

IPSC has a Capital Quality Rank of 62/100 — Above average. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track IPSC in DiviDrip

Add IPSC to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-06. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow